Medicine

Alzheimer's disease drug development pipeline: 2018

J. Cummings, Garam Lee, A. Ritter, K. Zhong

2018.5.3Alzheimers & Dementia-Translational Research & Clinical Interventions

DOI: 10.1016/j.trci.2018.03.009

tlooto Summary

Treatments for Alzheimer's disease (AD) are needed due to the growing number of individuals with preclinical, prodromal, and dementia forms of AD.

Abstract

Treatments for Alzheimer's disease (AD) are needed due to the growing number of individuals with preclinical, prodromal, and dementia forms of AD. Drug development for AD therapies can be examined by inspecting the drug development pipeline as represented on clinicaltrials.gov.

Citation format

CUMMINGS, J., et al. Alzheimer's disease drug development pipeline: 2018. Alzheimers & Dementia-Translational Research & Clinical Interventions, 2018, 4: 195–214.